This study looks back at medical records of 180 adults with lupus to compare two drugs: telitacicept and belimumab. The goal is to see which one works better at controlling the disease and has fewer side effects. Participants are not given any new treatment—researchers simply ana…
Sponsor: Yipeng Liu • Aim: Disease control
Last updated May 22, 2026 14:03 UTC